Longevity
Immorta Bio reports 70% lifespan gain in preclinical study
New peer-reviewed findings suggest tackling two hallmarks of aging at once may outperform single-target approaches. Much of medicine has approached aging the same way it approaches disease – identify a problem, find a target and develop a treatment – but aging has never been that simple. Aging is not one process, one malfunction or one […] The post Immorta Bio reports 70% lifespan gain in preclinical study appeared first on Longevity.Technology .
This story was reported by Longevity.Technology. EUROPES curates Europe's most relevant coverage — read the full report at the original source.
Read full coverage at Longevity.Technology →